Plain-English translation of NCT05388838 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new blood test that looks at special cells (called NK cells) in your blood to help doctors quickly identify a rare type of lymphoma that affects the eyes and brain. Right now, diagnosing this lymphoma is difficult and takes a very long time because the symptoms look like common eye inflammation. This simple blood test could help catch the disease much faster.
A rare type of lymphoma can hide in the eyes and look exactly like ordinary eye inflammation, making it very hard to diagnose. Without early detection, about half of patients develop brain involvement within 1 to 2 years, which makes the disease much more serious. This new blood test could help doctors spot the cancer early and start treatment before it spreads to the brain.
You likely qualify if…
You likely don't qualify if…
You will visit the research center for a blood draw — a simple needle stick to collect a small sample of your blood. The researchers will then analyze your blood cells in the laboratory to see if the new test can detect lymphoma. Depending on which group you are in, you may be a patient with eye inflammation, someone with known lymphoma, or a comparison participant without lymphoma. The study involves a single visit, though some participants may be followed over time if they are being monitored for disease progression or recovery.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
France